A Robust Phenotypic High-Throughput Antiviral Assay for the Discovery of Rabies Virus Inhibitors
Viruses · 2023
DOI: 10.3390/v15122292 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Xinyu Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Rega Institute, Department of Microbiology, Immunology and Transplantation, KU Leuven, Herestraat 49 Box 1043, 3000 Leuven, Belgium. Hauptthemen laut MEDLINE: Rabies virus, Rabies. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council.
Abstract (Originalsprache)
Rabies virus (RABV) causes severe neurological symptoms in mammals. The disease is almost inevitably lethal as soon as clinical symptoms appear. The use of rabies immunoglobulins (RIG) and vaccination in post-exposure prophylaxis (PEP) can provide efficient protection, but many people do not receive this treatment due to its high cost and/or limited availability. Highly potent small molecule antivirals are urgently needed to treat patients once symptoms develop. In this paper, we report on the development of a high-throughput phenotypic antiviral screening assay based on the infection of BHK-21 cells with a fluorescent reporter virus and high content imaging readout. The assay was used to screen a repurposing library of 3681 drugs (all had been studied in phase 1 clinical trials). From this series, salinomycin was found to selectively inhibit viral replication by blocking infection at the entry stage. This shows that a high-throughput assay enables the screening of large compound libraries for the purposes of identifying inhibitors of RABV replication. These can then be optimized through medicinal chemistry efforts and further developed into urgently needed drugs for the treatment of symptomatic rabies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rega Institute, Department of Microbiology, Immunology and Transplantation, KU Leuven, Herestraat 49 Box 1043, 3000 Leuven, Belgium.
- Cistim Leuven vzw, Bioincubator 2, Gaston Geenslaan 2, 3001 Leuven, Belgium.
- Center for Drug Design and Discovery (CD3), KU Leuven R&D, 3000 Leuven, Belgium.
ORCID-Profile: Winston Chiu, Arnaud Marchand, Johan Neyts, Dirk Jochmans
Förderung
- China Scholarship Council
Zitieren
APA
Wang, X., Chiu, W., Klaassen, H., Marchand, A., Chaltin, P., Neyts, J., & Jochmans, D. (2023). A Robust Phenotypic High-Throughput Antiviral Assay for the Discovery of Rabies Virus Inhibitors. Viruses. https://doi.org/10.3390/v15122292
Vancouver
Wang X, Chiu W, Klaassen H, Marchand A, Chaltin P, Neyts J, et al. A Robust Phenotypic High-Throughput Antiviral Assay for the Discovery of Rabies Virus Inhibitors. Viruses. 2023. doi:10.3390/v15122292
BibTeX
@article{Wang2023,
author = {Wang, Xinyu and Chiu, Winston and Klaassen, Hugo and Marchand, Arnaud and Chaltin, Patrick and Neyts, Johan and Jochmans, Dirk},
title = {A Robust Phenotypic High-Throughput Antiviral Assay for the Discovery of Rabies Virus Inhibitors},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15122292}
}
EUVIMED